An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

Carson C. Thoreen, Seong A. Kang, Jae Won Chang, Qingsong Liu, Jianming Zhang, Yi Gao, Laurie J. Reichling, Taebo Sim, David M. Sabatini, Nathaniel S. Gray

Research output: Contribution to journalArticle

1131 Citations (Scopus)

Abstract

The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.

Original languageEnglish
Pages (from-to)8023-8032
Number of pages10
JournalJournal of Biological Chemistry
Volume284
Issue number12
DOIs
Publication statusPublished - 2009 Mar 20
Externally publishedYes

Fingerprint

Sirolimus
Adenosine Triphosphate
Cell growth
Phosphotransferases
Cell Proliferation
Phosphorylation
mechanistic target of rapamycin complex 1
Autophagy
Cell proliferation
Immunosuppressive Agents
Growth
Tumors
Catalytic Domain
Neoplasms
Cell Survival

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., ... Gray, N. S. (2009). An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. Journal of Biological Chemistry, 284(12), 8023-8032. https://doi.org/10.1074/jbc.M900301200

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. / Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathaniel S.

In: Journal of Biological Chemistry, Vol. 284, No. 12, 20.03.2009, p. 8023-8032.

Research output: Contribution to journalArticle

Thoreen, CC, Kang, SA, Chang, JW, Liu, Q, Zhang, J, Gao, Y, Reichling, LJ, Sim, T, Sabatini, DM & Gray, NS 2009, 'An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1', Journal of Biological Chemistry, vol. 284, no. 12, pp. 8023-8032. https://doi.org/10.1074/jbc.M900301200
Thoreen, Carson C. ; Kang, Seong A. ; Chang, Jae Won ; Liu, Qingsong ; Zhang, Jianming ; Gao, Yi ; Reichling, Laurie J. ; Sim, Taebo ; Sabatini, David M. ; Gray, Nathaniel S. / An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 12. pp. 8023-8032.
@article{6df6a939febf49f08ac43547dfa41bc3,
title = "An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1",
abstract = "The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.",
author = "Thoreen, {Carson C.} and Kang, {Seong A.} and Chang, {Jae Won} and Qingsong Liu and Jianming Zhang and Yi Gao and Reichling, {Laurie J.} and Taebo Sim and Sabatini, {David M.} and Gray, {Nathaniel S.}",
year = "2009",
month = "3",
day = "20",
doi = "10.1074/jbc.M900301200",
language = "English",
volume = "284",
pages = "8023--8032",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

AU - Thoreen, Carson C.

AU - Kang, Seong A.

AU - Chang, Jae Won

AU - Liu, Qingsong

AU - Zhang, Jianming

AU - Gao, Yi

AU - Reichling, Laurie J.

AU - Sim, Taebo

AU - Sabatini, David M.

AU - Gray, Nathaniel S.

PY - 2009/3/20

Y1 - 2009/3/20

N2 - The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.

AB - The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.

UR - http://www.scopus.com/inward/record.url?scp=65549145048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549145048&partnerID=8YFLogxK

U2 - 10.1074/jbc.M900301200

DO - 10.1074/jbc.M900301200

M3 - Article

C2 - 19150980

AN - SCOPUS:65549145048

VL - 284

SP - 8023

EP - 8032

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -